Ernexa Therapeutics Inc.: Form 8-K, filed Dec 7, 2018
Filed with the SEC on Dec 7, 2018 and accepted by EDGAR at Dec 7, 2018, 08:35 ET.
Items reported
- Item 5.03 Amendment to articles or bylaws
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-18-017161. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.